Kris Vleminckx
- Molecular Biology top 5%
- Oncology top 5%
- Cell Biology top 2%
- Immunology and Allergy top 2%
- Cancer Research top 10%
- Co-authors
- Frans van RoyWalter FiersL. VakaetM. MareelRolf KemlerStefan VermeulenGeorges K. De BruyneMarcus Mareel
- Topics
- Wnt/β-catenin signaling in development and cancer (13 papers)Cancer-related gene regulation (6 papers)Cancer Cells and Metastasis (5 papers)
- Partner nations
- BelgiumUnited KingdomGermany
In The Last Decade
Kris Vleminckx
19 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Biology 1.9k
- Oncology 644
- Cell Biology 503
- Immunology and Allergy 297
- Cancer Research 220
Countries citing papers authored by Kris Vleminckx
This map shows the geographic impact of Kris Vleminckx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kris Vleminckx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kris Vleminckx more than expected).
Fields of papers citing papers by Kris Vleminckx
This network shows the impact of papers produced by Kris Vleminckx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kris Vleminckx. The network helps show where Kris Vleminckx may publish in the future.
Co-authorship network of co-authors of Kris Vleminckx
This figure shows the co-authorship network connecting the top 25 collaborators of Kris Vleminckx. A scholar is included among the top collaborators of Kris Vleminckx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kris Vleminckx. Kris Vleminckx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 67 | |
| 2 | 39 | |
| 3 | 281 | |
| 4 | 15 | |
| 5 | 55 | |
| 6 | Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells. | 135 |
| 7 | Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer | 5 |
| 8 | 11 | |
| 9 | Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells. | 53 |
| 10 | Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer. | 22 |
| 11 | 85 | |
| 12 | 30 | |
| 13 | 15 | |
| 14 | E-cadherin expression: a counterbalance for cancer cell invasion. | 42 |
| 15 | Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor rolebreakdown → | 1427 |
| 16 | 158 | |
| 17 | Numerical evaluation of the invasion of closely related cell lines into collagen type I gels. | 29 |
| 18 | Effect of oncogene transfection or passage in vivo on malignant phenotypes of rat2 cells. | 4 |
| 19 | 16 |
About Kris Vleminckx
Kris Vleminckx is a scholar working on Biotechnology, Oncology and Molecular Biology, having authored 19 papers that have together received 2.5k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (13 papers), Cancer-related gene regulation (6 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Immunology and Allergy (297 citations), Cell Biology (503 citations) and Molecular Biology (1.9k citations). Kris Vleminckx has collaborated with scholars based in Belgium, United Kingdom and Germany. Frequent co-authors include Frans van Roy, Walter Fiers, L. Vakaet, M. Mareel, Rolf Kemler, Stefan Vermeulen, Georges K. De Bruyne, Marcus Mareel, Marc Mareel and Erik Bruyneel. Their work appears in journals such as Cell, Journal of Biological Chemistry and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.